Drug allergies and ADR Flashcards
(37 cards)
(ADR) Adverse Drug Reaction:
is a term that encompasses all UNINTENDED PHARMACOLOGIC EFFECTS of a drug when it is administered correctly and used at recommended doses.
Effects from a drug when it is administered CORRECTLY.
ADR are typically DOSE-RELATED; the ADR severity increases with higher doses/reduced renal clearance.
Medication Error:
can include overdose and administration mistakes.
Something WRONG occurred, such as giving a medication dose to the WRONG person.
Urticaria (hives):
a rash with red/pinkish raised patches. the patches have varied shapes and sizes.
Pruritus (itching):
any rash or reaction that causes itching can be referred to as pruritis.
Erythema:
redness on the skin from superficial (near the surface) capillaries, often due to inflammation with pruritis. When pressed down, the red skin will blanch (whiten) temporarily because the blood flow is blocked. erythematous refers to an area on the skin, such as a patch, with erythema.
Angioedema:
Swelling caused by edema in the deeper dermal, cutaneous and submucosal tissue.
Morbilliform:
Macular or maculopapular rash (or both), with 1-10 mm lesions and healthy skin between the lesions.
(ADR) Adverse Drug Reactions:
are categorized into 2 types:
1)
2)
1) (Type A) predictable
2) (Type B) unpredictable
(Type A) predictable
- Dose-dependent
- predictable based on the drug’s pharmacology, pharmacologic actions
- can occur in anyone
- ranges from mild to severe
- ## most common, account for 80% of ADRs
ex. orthostatic hypotension with doxazosin, because of this risk, the dose of the medication should be slowly titrated.
(Type B) unpredictable
- NOT dose -dependent
- idiosyncratic: NOT predictable from drug’s pharmacology
- can be influenced by patient specific factors
Type B reactions include:
Drug allergies
Pseudoallergic reactions
Idiosyncratic reactions
ex. SJS
Type I Reactions:
IgE-mediated and immediate, within 60 minutes of drug exposure, ranging from minor local reactions to severe systemic reactions.
ex. urticaria, bronchospasm, angioedema, anaphylaxis,
Type II Reactions:
Antibody-mediated, occurring several days (usually 5-8 days) after drug exposure.
ex. hemolytic anemia, thrombocytopenia
Type III Reactions:
Immune Complex reactions, occurring > greater than or equal to 1 week after drug exposure.
ex. drug induced lupus erythematosus
Type IV Reactions:
Cell-mediated or delayed hypersensitivity reactions, occurring anytime from 48 hours to several weeks after drug exposure.
ex. Stevens-Johnson syndrome
Type I Reactions:
- occur right after drug has been taken, immediate (within 15-30 minutes of drug exposure).
- so, if taken orally, may take a little longer because drug has to get digested and be exposed to blood
- IgE-mediated allergic reaction
- severity ranges from minor inconvenience to death
- mostly due to Histamine release from basophils
- urticaria (hives), angioedema
Type II Reactions:
- minutes to hours after drug exposure
-ex. hemolytic anemia, thrombocytopenia (platelet count down a lot)
Type III Reactions:
- they occur 3-10 hours after drug exposure
-ex. drug-induced lupus and serum sickness
Type IV Reactions: “Delayed hypersensitivity reactions”
- they can take anywhere from 48 hours to several weeks after drug exposure.
- PPD skin test for tuberculosis, which peaks at 48-72 hours
- a lot are injectables
histamine comes from 2 types of cells:
- basophils
- mast cells
Boxed Warnings:
- the strictest warning.
- a boxed warning indicates a risk of death or permanent disability from a drug.
Contraindications:
- indicate that the drug CANNOT be used in that patient.
- The risk will outweigh any possible benefit.
e. a Hx of VTE is a contraindication to raloxifene (Evista )
raloxifene (Evista) is a selective estrogen receptor modulator (SERM): used to reduce the of hormone receptor-positive breast cancer in women with a higher than average risk of disease.
Warnings and Precautions:
- include serious reactions that can result in death, hospitalization, medical intervention, disability or teratogenicity.
- may or may not change a prescribing decision
Adverse Reactions:
- refer to undesirable, uncomfortable or dangerous effects from a drug (e.g. arthralgia from raloxifene).
- the risk-benefit assessment is patient specific
(REMS) Risk Evaluation and Mitigation Strategies:
- are developed by the manufacturer and approved by the FDA to ensure the benefits of a drug outweigh the risk.
- REMS programs can include a medication guide or patient package insert, communication plan, ELEMENTS TO ASSURE SAFE USE (ETASU) or an implementation system.
ex. the REMS for a drug could require prescribers or pharmacies to have a special certification to prescribe or dispense the drug, enroll patients in a registry so that ADRs can be tracked, or evaluate lab tests before dispensing.
ex.
clozapine REMS
isotretinoin iPLEDGE program
REMS to reduce misuse of long-acting opioids.
Medication Guides:
- are FDA approved patient handouts that detail a drug’s important adverse events in non-technical language.
-** are considered drug’s labeling
- if a medication has a MedGuide, it should be dispensed with the original prescription AND with each refill.
- There are required MedGuides for many individual drugs and, in some cases, entire classes of medications
- “think about what is the major toxicity that this drug/drug class has that the FDA is requiring the patient to have a MedGuide to learn about the drug”
(e.g.
anticonvulsants- suicide risk
antidepressants- suicidal ideation
long-acting opioids-
NSAIDs- cardiovascular effects, GI bleeding
ADHD stimulants- heart related problems
Medication Guides:
**The Medguides must be given to the patient:
- EVERY TIME the drug is dispensed to the patient in the outpatient setting- including with refills.
PLUS:
- the first time the drug is being dispensed to a healthcare provider for administration to a patient in an outpatient setting
- when the patient or patient’s caregiver requests it
- if the drug is subject to a Risk evaluation and Mitigation Strategy (REMS) that requires a MedGuide.
Naranjo scale: Assessing whether a drug caused an Adverse Drug Reaction (ADR).
- a validated causality assessment scale
- helps determine the likelihood that a drug caused an adverse reaction.
- is based on the questionnaire.
Score > greater or equal to 9 = definite ADR
Score 5-8 = probable ADR
Score 1-4 = possible ADR
Score 0 = doubtful ADR
Characterizing an Adverse Drug Reaction:
Pharmacists MUST Ask the Right Questions: Most patients are NOT registered pharmacists.
What reaction occurred? (e.g. mild rash, severe rash with blisters, trouble breathing)
When did it occur? About hold old, were you?
Can you use similar drugs in the class?
For example, for a penicillin allergy, ask if cephalexin has been used.
Do you have any food allergies or latex allergies?